The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have run a pilot project to encourage and motivate clinical-oncology scientists to participate in medicine regulation, focussing on scientific advice and marketing authorisation assessments for human medicines.

The pilot consisted of live and recorded webinars covering the following areas:

• Basic principles of the regulation of human medicines in the EU
• Basic regulatory aspects relevant to oncology

The recorded Webinars are publically available without registration at the